Research ArticleArticle

The Influence of Rheumatoid Arthritis Disease Characteristics on Heart Failure

ELENA MYASOEDOVA, CYNTHIA S. CROWSON, PAULO J. NICOLA, HILAL MARADIT-KREMERS, JOHN M. DAVIS III, VÉRONIQUE L. ROGER, TERRY M. THERNEAU and SHERINE E. GABRIEL
The Journal of Rheumatology August 2011, 38 (8) 1601-1606; DOI: https://doi.org/10.3899/jrheum.100979

REFERENCES

  1. 1.↵
    1. Mann DL,
    2. Bristow MR
    . Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 2005;111:2837–49.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Wang TJ,
    2. Evans JC,
    3. Benjamin EJ,
    4. Levy D,
    5. LeRoy EC,
    6. Vasan RS
    . Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003;108:977–82.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Crowson CS,
    2. Nicola PJ,
    3. Kremers HM,
    4. O’Fallon WM,
    5. Therneau TM,
    6. Jacobsen SJ,
    7. et al.
    How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005;52:3039–44.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. del Rincon ID,
    2. Williams K,
    3. Stern MP,
    4. Freeman GL,
    5. Escalante A
    . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737–45.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Nicola PJ,
    2. Maradit-Kremers H,
    3. Roger VL,
    4. Jacobsen SJ,
    5. Crowson CS,
    6. Ballman KV,
    7. et al.
    The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005;52:412–20.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Davis JM 3rd.,
    2. Roger VL,
    3. Crowson CS,
    4. Kremers HM,
    5. Therneau TM,
    6. Gabriel SE
    . The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 2008;58:2603–11.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Giles JT,
    2. Fernandes V,
    3. Lima JA,
    4. Bathon JM
    . Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 2005;7:195–207.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Maradit-Kremers H,
    2. Nicola PJ,
    3. Crowson CS,
    4. Ballman KV,
    5. Jacobsen SJ,
    6. Roger VL,
    7. et al.
    Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:76–80.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Setoguchi S,
    2. Greenberg J,
    3. Curtis JR,
    4. Hochberg MC,
    5. Reed G,
    6. Tsao P,
    7. et al.
    Markers of disease severity predict new-onset heart failure in rheumatoid arthritis [abstract]. Arthritis Rheum 2009;60 Suppl:S514.
    OpenUrl
  10. 10.↵
    1. Wolfe F,
    2. Michaud K
    . Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 2004;116:305–11.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Bernatsky S,
    2. Hudson M,
    3. Suissa S
    . Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis. Rheumatology 2005;44:677–80.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Davis JM 3rd.,
    2. Maradit Kremers H,
    3. Crowson CS,
    4. Nicola PJ,
    5. Ballman KV,
    6. Therneau TM,
    7. et al.
    Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007;56:820–30.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Listing J,
    2. Strangfeld A,
    3. Kekow J,
    4. Schneider M,
    5. Kapelle A,
    6. Wassenberg S,
    7. et al.
    Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 2008;58:667–77.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Maradit Kremers H,
    2. Crowson CS,
    3. Gabriel SE
    . Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004;30:819–34, vii.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Melton LJ 3rd.
    . History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266–74.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Arnett FC,
    2. Edworthy SM,
    3. Bloch DA,
    4. McShane DJ,
    5. Fries JF,
    6. Cooper NS,
    7. et al.
    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Ho KK,
    2. Pinsky JL,
    3. Kannel WB,
    4. Levy D
    . The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993;22 Suppl A:6A–13A.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Mosterd A,
    2. Deckers JW,
    3. Hoes AW,
    4. Nederpel A,
    5. Smeets A,
    6. Linker DT,
    7. et al.
    Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997;13:491–502.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Chobanian AV,
    2. Bakris GL,
    3. Black HR,
    4. Cushman WC,
    5. Green LA,
    6. Izzo JL Jr.,
    7. et al.
    Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–52.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.
    OpenUrlFREE Full Text
  21. 21.↵
    Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855–67.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26 Suppl 1:S5–20.
    OpenUrlCrossRefPubMed
  23. 23.↵
    Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28 Suppl 1:S37–42.
    OpenUrlFREE Full Text
  24. 24.↵
    1. Gillum RF,
    2. Fortmann SP,
    3. Prineas RJ,
    4. Kottke TE
    . International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J 1984;108:150–8.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Prineas RJ,
    2. Crow RS,
    3. Blackburn H
    . The Minnesota code manual of electrocardiographic findings: Standards and procedures for measurement and classification. Littleton, MA: Wright-PSG; 1982.
  26. 26.↵
    1. Turesson C,
    2. O’Fallon WM,
    3. Crowson CS,
    4. Gabriel SE,
    5. Matteson EL
    . Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722–7.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Turesson C,
    2. Jacobsson L,
    3. Bergstrom U
    . Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999;38:668–74.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Yndestad A,
    2. Damas JK,
    3. Oie E,
    4. Ueland T,
    5. Gullestad L,
    6. Aukrust P
    . Role of inflammation in the progression of heart failure. Curr Cardiol Rep 2007;9:236–41.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Gonzalez-Gay MA,
    2. Gonzalez-Juanatey C,
    3. Martin J
    . The increased risk of ventricular diastolic dysfunction and congestive heart failure in patients with rheumatoid arthritis is independent of the duration of the disease. Semin Arthritis Rheum 2005;35:132–3.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Ortega-Hernandez OD,
    2. Pineda-Tamayo R,
    3. Pardo AL,
    4. Rojas-Villarraga A,
    5. Anaya JM
    . Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis. Clin Rheumatol 2009;28:767–75.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Turesson C,
    2. McClelland RL,
    3. Christianson TJ,
    4. Matteson EL
    . Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:70–5.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Di Franco M,
    2. Paradiso M,
    3. Mammarella A,
    4. Paoletti V,
    5. Labbadia G,
    6. Coppotelli L,
    7. et al.
    Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease. Ann Rheum Dis 2000;59:227–9.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Udayakumar N,
    2. Venkatesan S,
    3. Rajendiran C
    . Diastolic function abnormalities in rheumatoid arthritis: relation with duration of disease. Singapore Med J 2007;48:537–42.
    OpenUrlPubMed
  34. 34.↵
    1. Naranjo A,
    2. Sokka T,
    3. Descalzo MA,
    4. Calvo-Alen J,
    5. Horslev-Petersen K,
    6. Luukkainen RK,
    7. et al.
    Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008;10:R30.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Westlake SL,
    2. Colebatch AN,
    3. Baird J,
    4. Kiely P,
    5. Quinn M,
    6. Choy E,
    7. et al.
    The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2010;49:295–307.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Lee DS,
    2. Gona P,
    3. Vasan RS,
    4. Larson MG,
    5. Benjamin EJ,
    6. Wang TJ,
    7. et al.
    Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute. Circulation 2009;119:3070–7.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Tribouilloy C,
    2. Rusinaru D,
    3. Mahjoub H,
    4. Souliere V,
    5. Levy F,
    6. Peltier M,
    7. et al.
    Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008;29:339–47.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Walsh CR,
    2. Larson MG,
    3. Evans JC,
    4. Djousse L,
    5. Ellison RC,
    6. Vasan RS,
    7. et al.
    Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2002;136:181–91.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Harrison BJ,
    2. Symmons DP,
    3. Barrett EM,
    4. Silman AJ
    . The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 1998;25:2324–30.
    OpenUrlPubMed
  40. 40.↵
    1. Karlson EW,
    2. Mandl LA,
    3. Hankinson SE,
    4. Grodstein F
    . Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses’ Health Study. Arthritis Rheum 2004;50:3458–67.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Plant D,
    2. Thomson W,
    3. Lunt M,
    4. Flynn E,
    5. Martin P,
    6. Eyre S,
    7. et al.
    The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology 2011;50:78–84.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section